Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Helix enrolling patients in phase II portion of phase I/II trial of L-DOS47 in NSCLC

April 29, 2016

AbbVie acquires Stemcentrx and its late-stage Rova-T compound

April 29, 2016

Advaxis' ADXS-HER2 gains FDA fast track status

April 29, 2016

First patient dosed in phase I trial of Agenus' AGEN-1884

April 28, 2016

SAR-428926, a novel ADC with promising activity in preclinical models of cancer

April 28, 2016

Tesaro submits IND for TSR-022

April 26, 2016

Opdivo granted fifth FDA breakthrough therapy designation

April 26, 2016

European Commission grants funding for development of new immunotherapy candidates

April 26, 2016

Alligator Bioscience receives milestone payment from Johnson & Johnson for ADC-1013 project

April 25, 2016

Hummingbird Bioscience and Sanofi collaborate to develop therapeutic antibodies for cancer

April 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...